{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:26:20Z","timestamp":1793597180337,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.seizure.2025.08.013","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T23:26:23Z","timestamp":1755041183000},"page":"4-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Effectiveness and safety of midazolam versus lorazepam for pediatric status epilepticus: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"132","author":[{"given":"Suzana","family":"Ezzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7860-4711","authenticated-orcid":false,"given":"Hassan K.","family":"Salamatullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhaii","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9665-9044","authenticated-orcid":false,"given":"Amal","family":"Alshrif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dania E.","family":"Faidah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0501-325X","authenticated-orcid":false,"given":"Jamil M.","family":"Baljoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2477-1339","authenticated-orcid":false,"given":"Alqassem Y.","family":"Hakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kholoud Abdullah","family":"Babkair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2025.08.013_bib0001","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0140-6736(06)69043-0","article-title":"Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study","volume":"368","author":"Chin","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.seizure.2025.08.013_bib0002","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/adc.2006.107516","article-title":"Outcome of convulsive status epilepticus: a review","volume":"92","author":"Novorol","year":"2007","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.seizure.2025.08.013_bib0003","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus \u2013 Report of the ILAE task force on classification of status epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2025.08.013_bib0004","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.seizure.2018.08.021","article-title":"The burden of pediatric status epilepticus: epidemiology, morbidity, mortality, and costs","volume":"68","author":"Gurcharran","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2025.08.013_bib0005","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/jamaneurol.2019.1268","article-title":"Change in mortality of generalized convulsive status epilepticus in high-income countries over time: a systematic review and meta-analysis","volume":"76","author":"Neligan","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.seizure.2025.08.013_bib0006","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/jcm5040047","article-title":"Management of status epilepticus in children","volume":"5","author":"Smith","year":"2016","journal-title":"JCM"},{"key":"10.1016\/j.seizure.2025.08.013_bib0007","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13049-019-0605-7","article-title":"Treatment delay in status epilepticus \u2013 more effective prehospital symptom recognition warranted","volume":"27","author":"Sairanen","year":"2019","journal-title":"Scand J Trauma Resusc Emerg Med"},{"issue":"1","key":"10.1016\/j.seizure.2025.08.013_bib0008","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American Epilepsy Society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.seizure.2025.08.013_bib0009","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1553-2712.2010.00751.x","article-title":"Midazolam Versus Diazepam for the treatment of status epilepticus in children and young adults: a meta-analysis","volume":"17","author":"McMullan","year":"2010","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.seizure.2025.08.013_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40261-020-00975-7","article-title":"Preferential antiseizure medications in pediatric patients with convulsive status epilepticus: a systematic review and network meta-analysis","volume":"41","author":"Zhang","year":"2021","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.seizure.2025.08.013_bib0011","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1177\/0883073816638757","article-title":"A comparison of midazolam, lorazepam, and diazepam for the treatment of status epilepticus in children: a network meta-analysis","volume":"31","author":"Zhao","year":"2016","journal-title":"J Child Neurol"},{"key":"10.1016\/j.seizure.2025.08.013_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108390","article-title":"Intranasal midazolam versus intravenous\/rectal benzodiazepines for acute seizure control in children: a systematic review and meta-analysis","volume":"125","author":"Chhabra","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2025.08.013_bib0013","series-title":"Cochrane handbook for systematic reviews of interventions [Internet]","author":"Higgins","year":"2019"},{"key":"10.1016\/j.seizure.2025.08.013_bib0014","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.seizure.2025.08.013_bib0015","series-title":"Cochrane handbook for systematic reviews of interventions","first-page":"205","article-title":"Assessing risk of bias in a randomized trial","author":"Higgins","year":"2019"},{"key":"10.1016\/j.seizure.2025.08.013_bib0016","doi-asserted-by":"crossref","first-page":"166","DOI":"10.32677\/IJCH.2018.v05.i03.005","article-title":"Comparing the effectiveness of intranasal midazolam and intravenous lorazepam for the treatment of acute seizures in children","volume":"05","author":"Bhadran","year":"2018","journal-title":"IJCH"},{"key":"10.1016\/j.seizure.2025.08.013_bib0017","first-page":"2651","article-title":"Intranasal Midazolam versus Intravenous lorazepam in the control of acute seizures in children aged 6 months to 15 years - An open label","volume":"7","author":"Khadir","year":"2020","journal-title":"Randomized Trial Jebmh"},{"key":"10.1016\/j.seizure.2025.08.013_bib0018","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s12098-011-0505-y","article-title":"Intravenous diazepam, midazolam and lorazepam in acute seizure control","volume":"79","author":"Gathwala","year":"2012","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.seizure.2025.08.013_bib0019","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/epi.12905","article-title":"Intramuscular midazolam versus intravenous lorazepam for the prehospital treatment of status epilepticus in the pediatric population","volume":"56","author":"Welch","year":"2015","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.seizure.2025.08.013_bib0020","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJMoa1107494","article-title":"Intramuscular versus intravenous therapy for prehospital status epilepticus","volume":"366","author":"Silbergleit","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2025.08.013_bib0021","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/epi.14479","article-title":"Rescue therapies for seizure emergencies: new modes of administration","volume":"59","author":"Maglalang","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2025.08.013_bib0022","doi-asserted-by":"crossref","first-page":"288","DOI":"10.18433\/J3NC79","article-title":"Intranasal drug delivery: how, why and what for?","volume":"12","author":"Pires","year":"2009","journal-title":"J Pharm Pharm Sci"},{"key":"10.1016\/j.seizure.2025.08.013_bib0023","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/jps.2600680119","article-title":"Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans","volume":"68","author":"Greenblatt","year":"1979","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.seizure.2025.08.013_bib0024","series-title":"Antiepileptic drugs","first-page":"187","article-title":"Benzodiazepines: chemistry, biotransformation, and pharmacokinetics","author":"Anderson","year":"2002"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131125002080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131125002080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T04:27:50Z","timestamp":1793593670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131125002080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":24,"alternative-id":["S1059131125002080"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2025.08.013","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and safety of midazolam versus lorazepam for pediatric status epilepticus: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2025.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}